Skip to content
You are not authorized to view this resource.
You need to login.
Please update your
to view content.
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Two Lots of Zoledronic Acid Injection, 5mg/100mL due to Potential Lack of Container Integrity
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Results
Sagent Pharmaceuticals Launches National Research Center in Chengdu, China
SAGENT PHARMACEUTICALS, SAGENT, INJECTABLES EXCELLENCE and DISCOVER INJECTABLES EXCELLENCE
are trademarks of Sagent Pharmaceuticals, Inc.©2007-2014 Sagent Pharmaceuticals, Inc.